Opportunity Information: Apply for AH TP2 15 002
Apply for AH TP2 15 002
- The Office of the Assistant Secretary for Health in the health sector is offering a public funding opportunity titled "Announcement of Availability of Funds for Rigorous Evaluation of New or Innovative Approaches to Prevent Teen Pregnancy (Tier 2B)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.297 Teenage Pregnancy Prevention Program.
- This funding opportunity was created on Jan 28, 2015 and posted on Jan 10, 2015.
- Applicants must submit their applications by Apr 10, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 30 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- 1. Eligible Applicants include Nonprofit with or without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities and colleges Research institutions Hospitals Community based organization Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska Native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federal States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Announcement of Availability of Funds for Rigorous Evaluation of New or Innovative Approaches to Prevent Teen Pregnancy (Tier 2B) is a discretionary federal funding opportunity from the Office of the Assistant Secretary for Health, administered through the Office of Adolescent Health (OAH), designed to grow the supply of evidence-based teen pregnancy prevention (TPP) interventions by funding rigorous evaluation studies of new or innovative approaches. The central aim is research and evaluation, not program service delivery. While participants may receive services as part of the intervention being tested, the intent of the grant is to build credible evidence about what works to reduce teen pregnancy and related adolescent sexual risk behaviors, and to produce interventions that can later be replicated and scaled if proven effective.
Applicants are expected to propose an intervention that is clearly needed, relevant to a defined target population, plausibly capable of reducing teen pregnancy and/or sexual risk behaviors, and structured in a way that allows for a strong evaluation design. OAH signals particular interest in projects that fill important gaps in the existing evidence base and that address sexual and reproductive health disparities. Priority populations and contexts highlighted include older adolescents (ages 18 to 19), males, rural youth, and other groups experiencing disproportionate risk of teen pregnancy. OAH is also interested in non-traditional delivery strategies, including approaches that are not strictly curriculum-based, suggesting openness to innovative formats, settings, or delivery channels so long as they are researchable and measurable.
The work supported under this cooperative agreement is framed as a phased process with clear expectations. Grantees are expected to actively engage the target population in developing or finalizing the intervention, rather than designing in isolation from the people the program is meant to serve. The award includes a substantial planning, piloting, and readiness period of roughly 6 to 12 months before full implementation, emphasizing that interventions should be refined and made operationally ready prior to being tested at scale. After that, grantees must implement and rigorously evaluate the intervention, using methods strong enough to credibly attribute outcomes to the program. Alongside the impact evaluation, projects are expected to collect and use performance measure data for continuous quality improvement, ensuring that implementation issues are identified and addressed rather than ignored.
OAH also sets quality and inclusion standards for the intervention content and materials. Funded interventions must be medically accurate, age-appropriate, culturally and linguistically appropriate for the communities served, and inclusive of LGBTQ youth. Beyond producing evaluation findings, grantees are expected to document and package the intervention so it is implementation-ready and replicable if results show effectiveness. Dissemination is an explicit deliverable as well, meaning grantees must share evaluation results and intervention information with the field to strengthen broader practice and policy, not just produce internal reports.
The FOA draws firm boundaries around what is not eligible for funding. Projects cannot evaluate programs that are already identified as evidence-based by the HHS TPP Evidence Review. It also excludes significant adaptations of those already-evidence-based programs, as well as programs that were already being rigorously evaluated under the earlier OPHS/OAH TPP PREP Tier 2 FOA first funded in fiscal year 2010 (with a list referenced in the announcement’s appendix). In other words, Tier 2B is meant to expand the universe of tested interventions, not re-test existing ones or fund work that overlaps substantially with ongoing federal evaluations.
This opportunity aligns with several major federal public health frameworks and priorities. It supports HHS strategic goals focused on improving outcomes for children and youth, eliminating health disparities, and accelerating scientific discovery to improve health. It also aligns with Healthy People 2020 goals related to health equity, healthy development across life stages, and objectives spanning family planning, sexually transmitted diseases, HIV, adolescent health, and LGBTQ health. Additionally, it supports the National Prevention Strategy’s emphasis on helping people make healthy choices and eliminating disparities, including recommendations to provide effective sexual health education for adolescents and to improve early detection and linkage to care for HIV, viral hepatitis, and other STIs.
Administratively, the funding opportunity number is AH-TP2-15-002 under CFDA 93.297 (Teenage Pregnancy Prevention Program). The instrument is a cooperative agreement, indicating ongoing federal involvement or collaboration beyond a standard grant. The FOA anticipated up to 30 awards, with award amounts ranging from $400,000 to $1,000,000, and it did not require cost sharing or matching. Eligibility was broad and included nonprofits (with or without 501(c)(3) status, excluding institutions of higher education in that particular nonprofit category), for-profit organizations (other than small businesses), small/minority/women-owned businesses, colleges and universities, research institutions, hospitals, community- and faith-based organizations, tribal governments and tribally designated organizations (including Alaska Native entities, Urban Indian organizations, and tribal epidemiology centers), and state and local governments or their bona fide agents, including U.S. territories and affiliated jurisdictions. The original posting date was January 10, 2015, with an application closing date of April 10, 2015, and an archive date of May 10, 2015.
For assistance, the announcement lists OASH Office of Adolescent Health contacts under “OAH TPP Tier 2B,†including a phone number (240-453-2846) and the email address tpptier2b@hhs.gov for program requirements or technical assistance.
Frequently Asked Questions (FAQs)
What is the purpose of the Rigorous Evaluation of New or Innovative Approaches to Prevent Teen Pregnancy (Tier 2B) funding opportunity?
This funding opportunity is intended to grow the supply of evidence-based teen pregnancy prevention (TPP) interventions by supporting rigorous evaluation studies of new or innovative approaches. The primary purpose is research and evaluation: building credible evidence about what works to reduce teen pregnancy and related adolescent sexual risk behaviors, and developing interventions that can later be replicated and scaled if they prove effective.
Is this grant meant to fund direct program services for youth?
No. The central aim is research and evaluation rather than program service delivery. Participants may receive services as part of the intervention being tested, but the grant is designed to generate strong evidence and produce an intervention that can be packaged for replication if effective.
What types of projects does OAH want applicants to propose?
Applicants are expected to propose an intervention that is clearly needed, relevant to a defined target population, plausibly capable of reducing teen pregnancy and/or adolescent sexual risk behaviors, and structured so it can be evaluated using a strong design that can credibly attribute outcomes to the intervention.
What kinds of target populations or settings are of particular interest?
OAH signals particular interest in projects that fill important gaps in the existing evidence base and address sexual and reproductive health disparities. Populations and contexts highlighted include older adolescents (ages 18 to 19), males, rural youth, and other groups experiencing disproportionate risk of teen pregnancy.
Are non-traditional or non-curriculum-based approaches allowed?
Yes. The opportunity explicitly notes interest in non-traditional delivery strategies and approaches that are not strictly curriculum-based. Innovative formats, settings, or delivery channels are acceptable as long as the approach is researchable and measurable and can be evaluated rigorously.
What is the expected project structure or timeline?
The cooperative agreement is framed as a phased process. It includes a substantial planning, piloting, and readiness period of about 6 to 12 months before full implementation. After that, the grantee is expected to implement and rigorously evaluate the intervention at scale.
Does the project need to involve the target population in intervention development?
Yes. Grantees are expected to actively engage the target population in developing or finalizing the intervention rather than designing it in isolation from the people the program is intended to serve.
How rigorous does the evaluation need to be?
The evaluation methods must be strong enough to credibly attribute outcomes to the program. The intent is to produce credible evidence about whether the intervention reduces teen pregnancy and/or related adolescent sexual risk behaviors.
Are performance measures required in addition to the impact evaluation?
Yes. Alongside the impact evaluation, projects are expected to collect and use performance measure data for continuous quality improvement so implementation issues are identified and addressed.
What standards apply to the intervention content and materials?
Funded interventions must be medically accurate, age-appropriate, culturally and linguistically appropriate for the communities served, and inclusive of LGBTQ youth.
What are the expectations for packaging the intervention and sharing results?
Beyond producing evaluation findings, grantees are expected to document and package the intervention so it is implementation-ready and replicable if results show effectiveness. Dissemination is also an explicit deliverable, meaning grantees must share evaluation results and intervention information with the field.
What projects are not eligible for Tier 2B funding?
Tier 2B cannot be used to evaluate programs that are already identified as evidence-based by the HHS TPP Evidence Review. It also excludes significant adaptations of those evidence-based programs and excludes programs already being rigorously evaluated under the earlier OPHS/OAH TPP PREP Tier 2 FOA first funded in fiscal year 2010 (referenced in the announcement appendix). The goal is to expand the universe of tested interventions rather than re-test existing ones or overlap with prior federal evaluations.
What federal priorities or frameworks does this opportunity align with?
This opportunity aligns with HHS strategic goals related to improving outcomes for children and youth, eliminating health disparities, and accelerating scientific discovery. It also aligns with Healthy People 2020 goals and objectives spanning health equity, healthy development, family planning, sexually transmitted diseases, HIV, adolescent health, and LGBTQ health. In addition, it supports the National Prevention Strategy emphasis on helping people make healthy choices and eliminating disparities, including recommendations related to effective sexual health education and improved detection and linkage to care for HIV, viral hepatitis, and other STIs.
What is the funding opportunity number and CFDA number?
The funding opportunity number is AH-TP2-15-002 and the CFDA number is 93.297 (Teenage Pregnancy Prevention Program).
What type of award instrument is this?
This opportunity uses a cooperative agreement, which indicates ongoing federal involvement or collaboration beyond what is typically expected under a standard grant.
How many awards were anticipated and what was the award size?
The FOA anticipated up to 30 awards. Award amounts were expected to range from $400,000 to $1,000,000.
Is cost sharing or a match required?
No. The FOA did not require cost sharing or matching.
Who was eligible to apply?
Eligibility was broad and included nonprofits (with or without 501(c)(3) status, excluding institutions of higher education in that particular nonprofit category), for-profit organizations (other than small businesses), small/minority/women-owned businesses, colleges and universities, research institutions, hospitals, community- and faith-based organizations, tribal governments and tribally designated organizations (including Alaska Native entities, Urban Indian organizations, and tribal epidemiology centers), and state and local governments or their bona fide agents, including U.S. territories and affiliated jurisdictions.
When was the opportunity posted and when were applications due?
The original posting date was January 10, 2015. The application closing date was April 10, 2015. The archive date was May 10, 2015.
Who can be contacted for program requirements or technical assistance?
The announcement lists OASH Office of Adolescent Health contacts under "OAH TPP Tier 2B." Assistance is available by phone at 240-453-2846 or by email at tpptier2b@hhs.gov.
Browse more opportunities from the same category: Health
Next opportunity: Announcement of Availability of Funds for a National Resource Center for HIV/AIDS Prevention Among Adolescents
Previous opportunity: FY15 Announcement of Availability of Funds for Supporting and Enabling Early Innovation to Advance Adolescent Health and Prevent Teen Pregnancy (Tier 2A)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for AH TP2 15 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (AH TP2 15 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Announcement of Availability of Funds for a National Resource Center for HIV/AIDS Prevention Among Adolescents Apply for AH MAI 15 001 Funding Number: AH MAI 15 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $350,000 |
| Novel Assays to Address Translational Gaps in Treatment Development (UH2/UH3) Apply for RFA MH 16 220 Funding Number: RFA MH 16 220 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Novel and Emerging Technologies to Support Zebrafish Models for Biomedical Research (R41/R42) Apply for PA 15 087 Funding Number: PA 15 087 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Novel and Emerging Technologies to Support Zebrafish Models for Biomedical Research (R43/R44) Apply for PA 15 086 Funding Number: PA 15 086 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Reducing the burden of neglected parasitic infections (NPIs) in the United States through evidence based prevention and control activities Apply for CDC RFA GH15 1617 Funding Number: CDC RFA GH15 1617 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Shared Instrumentation Grant (SIG) Program (S10) Apply for PAR 15 088 Funding Number: PAR 15 088 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| FY15 Research, Monitoring and Outcomes Definitions for Vaccine Safety Apply for NV VSR 15 001 Funding Number: NV VSR 15 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $250,000 |
| US Platform to Measure Influenza Vaccine Effectiveness against Laboratory confirmed Influenza associated Apply for RFA IP 15 002 Funding Number: RFA IP 15 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Increasing Participation of People with Disabilities in USAID Activities and Strengthen the Capacities of Disabled Peoples Organizations (DPOs). Apply for RFA 114 15 000006 Funding Number: RFA 114 15 000006 Agency: Georgia USAID Tbilisi Category: Health Funding Amount: $600,000 |
| Maternal Newborn and Child Health Activity Apply for RFA 611 15 000001 Funding Number: RFA 611 15 000001 Agency: Zambia USAID Lusaka Category: Health Funding Amount: $7,500,000 |
| Program Expansion Supplement for GH11 1109, Strengthening Local Capacity to Provide Sustainable HIV Related Care and Treatment Services in South Africa under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 11090501SUPP15 Funding Number: CDC RFA GH11 11090501SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $24,000,000 |
| Analyze and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) Apply for RFA TS 15 001 Funding Number: RFA TS 15 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| R40 MCH Autism Secondary Data Analysis Studies Program Apply for HRSA 15 083 Funding Number: HRSA 15 083 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Quality Improvement Capacity for Impact Project Apply for HRSA 15 021 Funding Number: HRSA 15 021 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIGMS Program of Administrative Supplements for Equipment (Admin Supp) Apply for PA 15 089 Funding Number: PA 15 089 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Hospital Preparedness Program (HPP) and Public Health Emergency Preparedness (PHEP) Cooperative Agreements / PHEP Supplemental for Ebola Preparedness and Response Activities Apply for CDC RFA TP12 12010302SUPP15 Funding Number: CDC RFA TP12 12010302SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $9,232,987 |
| NIAMS Rheumatic Diseases Research Resource based Centers (P30) Apply for RFA AR 16 002 Funding Number: RFA AR 16 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Stillbirth Risk Factor Pilot Project Centers for Birth Defects Research and Prevention (CBDRPs) Apply for RFA DD 15 004 Funding Number: RFA DD 15 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Drug Free Communities Support Program Apply for SP 15 001 Funding Number: SP 15 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $125,000 |
| Cooperative Agreement for Networking, Certifying, and Training Suicide Prevention Hotlines and Disaster Distress Helpline Apply for SM 15 007 Funding Number: SM 15 007 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $6,211,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "AH TP2 15 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.